Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

GP Hodsman, JJ Brown, DL Davies, R Fraser… - Br Med J (Clin Res …, 1982 - bmj.com
Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in single daily
doses of 1.25-40 mg was assessed in five patients with hypertension and renal artery …
被引用次数：53 相关文章

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

GP Hodsman, JJ Brown, DL Davies… - British Medical …, 1982 - search.proquest.com
Abstract Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in
single daily doses of 1.25-40 mg was assessed in five patients with hypertension and renal …

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

GP Hodsman, JJ Brown, DL Davies… - … (Clinical research ed …, 1982 - ncbi.nlm.nih.gov
Abstract Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in
single daily doses of 1.25-40 mg was assessed in five patients with hypertension and renal …

[引用][C] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK 421) IN TREATMENT OF HYPERTENSION WITH RENAL ARTERY STENOSIS

GP HODSMAN, B JJ, D DL, R FRASER, L AF - 1982 - pascal-francis.inist.fr
CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK 421) IN TREATMENT OF
HYPERTENSION WITH RENAL ARTERY STENOSIS CNRS Inist Pascal-Francis CNRS …

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

GP Hodsman, JJ Brown, DL Davies… - … (Clinical Research ed …, 1982 - europepmc.org
Abstract Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in
single daily doses of 1.25-40 mg was assessed in five patients with hypertension and renal …

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis

GP Hodsman, JJ Brown, DL Davies… - British medical …, 1982 - pubmed.ncbi.nlm.nih.gov
Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in single daily
doses of 1.25-40 mg was assessed in five patients with hypertension and renal artery …

Converting-Enzyme Inhibitor Enalapril (MK421) In Treatment Of Hypertension With Renal Artery Stenosis

GP Hodsman, JJ Brown, DL Davies, R Fraser… - British Medical Journal …, 1982 - JSTOR
Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in single daily
doses of 1.25-40 mg was assessed in five patients with hypertension and renal artery …

[引用][C] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS

GP HODSMAN, JJ BROWN, DL DAVIES… - British Medical …, 1982 - research.ed.ac.uk
CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION
WITH RENAL-ARTERY STENOSIS — University of Edinburgh Research Explorer Skip to main …

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

GP Hodsman, JJ Brown, DL Davies… - … (Clinical Research ed …, 1982 - europepmc.org
Abstract Enalapril maleate (MK421), a new inhibitor of angiotensin converting enzyme, in
single daily doses of 1.25-40 mg was assessed in five patients with hypertension and renal …